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Abstract 
Purpose: To develop a rapid and reliable reverse phase high performance liquid chromatography (RP-
HPLC) method to quantify the two isomers of asarones in P. sarmentosum extracts using two different 
columns under similar analytical conditions.  
Methods: Two isomers, α- and β-asarone, were analyzed using two types of C-18 columns with 0.1 % 
orthophosphoric acid: acetonitrile: methanol (50: 40: 10) as mobile phase. The developed method was 
applied to determine the contents of α- and β-asarone in extracts of different parts of P. sarmentosum.  
Results: Column A retention times for the elution of α- and β-asarone were 11.890 ± 0.008 and 10.80 ± 
0.004 min, respectively, and were significantly shorter than those of column B (15.110 ± 0.024 and 
13.290 ± 0.018, respectively, p < 0.001). Column B showed better resolution (1.82 ± 0.025 of the 
isomers than column A (1.10 ± 0.01, p < 0.001). Both columns showed comparable sensitivity, precision 
and selectivity of the compounds investigated. α-Asarone level was in the range 0.36 - 5.14 % in 
ethanol and 50 % ethanol extracts, but absent in all water extracts. β-Asarone occurred in the range of 
0.01 - 0.15 % in ethanol and 50 % ethanol extracts but was absent in all water extracts of P. 
sarmentosum. 
Conclusion: The results indicate that the developed method is a suitable quality assurance method for 
determining α- and β-asarone isomers in herbal extracts and food preparations. 
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Piper sarmentosum Roxburgh (family: 
Piperaceae) is a herbaceous shrub, and is most 
widely distributed in Southeast Asia including 
Malaysia, Cambodia, Laos, Philippines, 
Myanmar, Thailand, Vietnam and China [1]. The 
plant has been investigated for a number of 
pharmacological activities such as hypoglycemic 
[2], anti-amoebic [3], antibacterial [4], 
neuromuscular blocking [5], anti-malarial [6], 
antioxidant [7], anti-tuberculosis [8], anticancer 
[9] and anti-angiogenic activity [10].  
 
The chemical constituents identified from the 
plant include (2E, 4E)-N-isobutyldecadienamide, 
N-(2-phenylpropanoyl) pyrrole, sarmentine, 
sarmentosine, 1-(3,4-methylenedioxyphenyl)-
(1E)-tetradecane, 1-allyl-2,6-demethoxy-3,4-
methylenedioxybenzene, asaricin, α-asarone, γ-
Hamil et al 
Trop J Pharm Res, January 2016; 15(1): 158  
 
asarone, hydrocinnamic, oxalic acids, sitosterol 
and naringenin [11,12]. Asarones are mostly 
found in isomers i.e. cis- and trans-forms. The 
trans-asarone or α-asarone chemically known as 
(E)-1,2,4-trimethoxy-5-(prop-1-en-1-yl) benzene 
while cis-asarone or β-asarone  known as (Z)- 
1,2,4-trimethoxy-5-(prop-1-en-1-yl)benzene.  
 
Apart from showing biological activities, i.e. 
anthelmintic, pesticidal and neuroprotective [13, 
14], both α- and β-asarones are also known as 
carcinogenic and genotoxic compounds [15,16]. 
β-asarone possesses toxic and sterilizing effects 
[17] whereas α-asarone showed greater 
cytotoxic effect [18].  
 
In food and herbal industries it is required that 
the quantity of asarones be limited to ascertain 
the products safety [19-21]. Therefore, analysis 
of these asarone isomers in P. sarmentosum is 
important for its quality control in herbal remedy 
preparation. 
 
This study was conducted in order to develop 
and validate a simple and robust RP-HPLC 
method for the quantification of α- and β-
asarones in different extracts of P. sarmentosum 
without using large quantity of organic solvents 
and special stationary phase or modifiers for the 




Preparation of raw material  
 
P. sarmentosum plant was collected from Batu 
Gajah, Malaysia. The plant samples were 
identified by Dr. Rahmad Zakaria from School of 
Biological Sciences, Universiti Sains Malaysia 
and the specimen vouchers were deposited at 
School of Biological Sciences, Universiti Sains 
Malaysia with voucher number 
USM/Herbarium/11481. The plant samples which 
were divided into four different parts (leaf, stem, 
root and fruit) were ground into powder form 
using an electric grinder SM-100 (Retsch, 
Germany).  
 
Chemicals and reagents 
 
All solvents used were of HPLC grade and were 
acquired from Merck Sdn. Bhd. (Selangor, 
Malaysia). Authentic α- and β-asarones were 
obtained from Sigma-Aldrich (M) Sdn. Bhd 
(Kuala Lumpur, Malaysia).  Two C-18 columns 
(250 × 4.6 mm, 5 µm); (A) ZORBAX Eclipse Plus 
Phenyl-Hexyl and (B) ZORBAX Eclipse Plus 
were purchased from Agilent Technologies 
(USA). 
 
Preparation of extracts 
 
All extracts were prepared by maceration of 
powdered material with 99 % ethanol, 50 % 
ethanol and water solvents at 60 °C for 48 h. All 
extracts were filtered; the solvent was 
evaporated to dryness using rotary evaporator R-
100 (Buchi, Switzerland) at 40 °C. Extracts were 
labeled as PSL-E, PSL-EW, PSL-W, PSS-E, 
PSS-EW, PSS-W, PSR-E, PSR-EW, PSR-W, 
PSF-E, PSF-EW and PSF-W, respectively, 
where PS = P. sarmentosum, L = leaves, S = 
Stem, R = roots, F = fruits, EW = ethanol: water 
(50: 50), W = water, E = ethanol.  
 
Instrumentation and HPLC conditions 
 
All experiments were performed using an Agilent 
Technologies 1260 infinity (USA) HPLC system 
with UV detector, quaternary pump, online 
degasser, and column incubator. Separation was 
done on two different C-18 columns (250 × 4.6 
mm, 5 µm) (A) ZORBAX Eclipse Plus Phenyl-
Hexyl, C-18 column and (B) ZORBAX Eclipse 
Plus C-18 made by Agilent Technologies (USA), 
using an isocratic mobile phase consisting 0.1 % 
phosphoric acid : acetonitrile : methanol 50 : 40 : 
10, the flow rate was set at 1 ml/min, column 
temperature was maintained at 30 °C, and 
detection was performed at 210 nm. Injection 
volume was 10 µL and data acquisition was 
carried out by Agilent ChemStation software for 
LC systems.  
 
Preparation of the standard mixture  
 
A stock solution of a mixture of α- and β-asarone 
was prepared at 1 mg/mL in HPLC grade 
methanol, and serial dilutions were prepared in 
the range 0.44 – 250 µg/mL. P. sarmentosum 
extracts were also prepared at 10 mg/mL in the 
same solvent and were further diluted to 1 
mg/mL with methanol. Both, samples and 
standard stock solution were filtered through 0.45 




The proposed method was validated on both 
columns according to the ICH guidelines [22]. 
The following validation characteristics were 
evaluated: selectivity, linearity, precision, 
accuracy and the limits of detection and 




Linearity was determined by injecting 10 µL of 
the standard mixture in the concentration range 
Hamil et al 
Trop J Pharm Res, January 2016; 15(1): 159  
 
0.448 - 250 µg/mL. The calibration curves were 
obtained by plotting peak area versus 
concentration, and linearity (R2) was determined 




The selectivity of method was determined by 
comparing the retention time of target 
compounds obtained in the sample extracts with 
their reference counterparts, and by spiking the 





Precision was determined as the coefficient of 
variation (% CV) of peak area and retention time. 
The standard mixture was analyzed at 5 
concentrations in the range 7.81 - 125 µg/mL, 
and the intraday, interday and intermediate 




Accuracy was determined as a percentage 
recovery of α- and β-asarone at 3.16, 6.25 and 
12.5 µg/mL added to the ethanol extract at 1000 
µg/mL. The peak area corresponding to the 
compounds in the ethanol extract (B), the 
individual reference compounds (C) and their 
combinations (A) were recorded. The percentage 
recovery was then calculated using the following 
formula: % Recovery = ((A – B) / C) × 100. The 
results are presented average ± SD (n = 3). 
 
Limits of detection (LOD) and of 
quantification (LOQ) 
 
The LOD and LOQ were calculated from the 
slope and standard deviation method as in Eqs 1 
and 2.  
 
LOD = (3.3 × δ)/S …………………………… (1) 
 
LOQ = (10 × δ)/S ….………………………… (2) 
 
Where δ = is the standard deviation of the Y 
intercept of the linear regression equation. S = 
the slope of the linear regression equation [22]. 
 
Determination of α- and β-asarone 
concentration in P. sarmentosum extracts   
 
Three different extracts from 4 parts of P. 
sarmentosum were analyzed for asarone 
contents (Figures 2 and 3). Concentrations of α-
and β-asarones were calculated by applying the 
linear regression equations of the reference 
compounds. The identifications of asarones were 
done by comparing the retention times to those 
of standards, as well as adding the individual 
standard to the samples. P. sarmentosum 
extracts (10 µL) were injected at 1000 µg/mL, 
and the peak areas corresponding to α- and β-
asarone were recorded. The linear regression 
equations of the standard calibration curves were 
applied to calculate the concentrations of the 
marker compounds, and the results are 
presented as mean % wt/wt using the formula: % 





Statistical calculations were carried out using 
SPSS 20.0 software package. Independent 
sample t-test was applied and the differences 




It is reported that trans/α- isomers stays for a 
longer time in column as compared cis/β-isomer 
[23].  So in the present study, it was observed 
that with each column the cis/β-asarone had a 
lower retention time than the trans/α-asarone. In 
terms of column comparison, we found that 
column A has significantly shorter retention time 
for the elution of α- and β-asarone which were 
11.89 ± 0.008 min and 10.80 ± 0.004 min  
compared to column B 15.11 ± 0.024 min and 
13.29 ± 0.018 min, (Figure 1). The 
dimethylphenylhexylsilane stationary phase in 
column A was able to elute the target 
compounds faster than column B which 
contained dimethyl-n-octadecylsilane stationary 
phase. Column B showed better resolution (1.82 
± 0.025 min difference between) of the isomers 
as compared to column A (1.10 ± 0.01 min 
difference) which was statistically significant, p < 
0.001. We also found that both columns showed 
comparable sensitivity, precision and selectivity 
of the compounds investigated. Column A had 
higher sensitivity with lower LOD and LOQ 




The selectivity of the method was determined by 
comparing the retention times of α- and β-
asarone obtained in the sample extracts with 
those of the reference compounds on both 
columns. The retention time of α- and β-asarone 
was 11.8 ± 0.002 and 10.79 ± 0.021 min on 
column A while it was 15.09 ± 0.01 and 13.26 ± 
0.02 min for column B respectively. 
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Figure 1: HPLC chromatograms of α- and β-asarone at 210 nm. A = ZORBAX Eclipse Plus Phenyl-Hexyl C-18 
column, B = ZORBAX Eclipse Plus C-18 column 
 
Their counterparts in P. sarmentosum extracts 
were eluted at 11.81 ± 0.002 and 10.8 ± 0.03 min 
on column A while they eluted 15.28 ± 0.67 and 
13.33 ± 0.03 min, respectively, on column B. 
Spiking the extracts with α- and β-asarone 
increased the peak areas of the compounds 
without any shift in the retention times and 
appearance of extra peaks. This further 
confirmed the identity of the compounds and the 




Linearity was presented in terms of the 
regression coefficient (R2) of the regression 
equations of reference compounds (R2) was 
0.999 ± 0.001 for both α- and β-asarone which 
indicate good linearity of the proposed method 




The precision was calculated in terms of the % 
CV of the retention time and peak area (Table 1 
and 2). The α- and β-asarone were eluted at 
11.800 ± 0.002 and 10.790 ± 0.021 min on 
column A with CV of < 0.05 %, and 15.09 ± 0.01 
min and 13.26 ± 0.02 min with a % CV of < 0.42 
% on column B, respectively.  The % CV of the 
peak areas were calculated in the concentration 
range 7.81 - 125 µg/mL with an average of < 
0.05 and < 0.20 % on columns A and B 
respectively. These results indicated good 
reproducibility of retention times and peak areas 
on both columns. 
 
Accuracy and recovery 
 
The results are presented as recovery of the 
reference compounds, viz, 31.25, 62.5, and 125 
µg/mL ranging from 97 ± 0.50 and 99 ± 0.5 % for 
columns A and B, respectively.  
 
LOD and LOQ 
 
The LOD and LOQ of α- and β-asarone with 
column A and B were calculated and presented 
in Table 2. 
 
α- and β-asarone in extracts of P. 
sarmentosum  
 
Asarone contents in the extracts of different parts 
of P. sarmentosum varied between the samples 
and are shown in Table 3. The α-asarone was 
found from 0.36 - 5.14 % in ethanol and 50 % 
ethanol extracts of P. sarmentosum parts and 
absent in all water extracts. β-asarone was found 
in lesser amounts in the ranges from 0.01 - 0.15 
% in ethanol and 50 % ethanol extract and was 
absent in all water extracts of different parts of P. 
sarmentosum. 
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Table 1: Precision analysis of α- and β-asarone using both columns 
 
α-asarone 
Precision Column A Column B 
Intraday Conc. 
(µg/mL) 
PA (mAU*S) AV±SD % CV RT (min) AV±SD % CV PA (mAU*S) AV±SD % CV RT (min) AV±SD % CV 
125 8021.0 ± 1.42 0.02 11.89 ± 0.005 0.04 8005.16 ± 3.10 0.04 15.08 ± 0.01 0.08 
62.5 4236.8 ± 0.45 0.02 11.89 ± 0.005 0.04 4263.42 ± 2.31 0.05 15.09 ± 0.00 0.03 
31.25 2080.8 ± 0.84 0.04 11.90 ± 0.007 0.05 2160.56 ± 1.89 0.09 15.15 ± 0.01 0.04 
15.625 1075.8 ± 1.09 0.10 11.89 ± 0.004 0.03 1097.52 ± 2.78 0.25 15.14 ± 0.01 0.04 
7.8125 542.0 ± 0.00 0.00 11.87 ± 0.043 0.36 568.20 ± 1.07 0.19 15.15 ± 0.01 0.06 
Interday 125 8022.4 ± 1.14 0.01 11.90 ± 0.01 0.01 7967.56 ± 1.67 0.02 15.09 ± 0.00 0.02 
62.5 4235.8 ± 1.09 0.02 11.89 ± 0.02 0.02 4263.87 ± 1.99 0.05 15.09 ± 0.01 0.04 
31.25 2082 ± 0.70 0.03 11.90 ± 0.03 0.01 2138.23 ± 2.49 0.12 15.09 ± 0.01 0.07 
15.625 1075.2 ± 0.83 0.07 11.90 ± 0.01 0.01 1097.75 ± 1.97 0.18 15.09 ± 0.01 0.06 




125 8022.4 ± 1.14 0.01 11.90 ± 0.09 0.02 7986.36 ± 1.00 0.01 15.09 ± 0.01 0.04 
62.5 8021.7 ± 0.99 0.01 11.89 ± 0.002 0.01 4263.65 ± 0.22 0.01 15.09 ± 0.00 0.01 
31.25 4236.3 ± 0.71 0.01 11.89 ± 0.001 0.00 2149.39 ± 0.42 0.02 15.12 ± 0.00 0.02 
15.625 2081.4 ± 0.85 0.04 11.90 ± 0 0.01 1097.64 ± 0.58 0.05 15.11 ± 0.00 0.02 
7.8125 1075.5 ± 0.42 0.03 11.89± 0.001 0.11 566.09 ± 1.66 0.29 15.12 ± 0.00 0.00 
β-asarone 
Intraday 125 8389.6 ± 1.1 0.01 10.79 ± 0.005 0.05 7977.84 ± 1.71 0.02 13.31 ± 0.00 0.00 
62.5 4485.8 ± 1.7 0.03 10.79 ± 0.005 0.05 4190.78 ± 2.60 0.06 13.31 ± 0.00 0.00 
31.25 2243.6 ± 1.1 0.05 10.79 ± 0.008 0.08 2193.30 ± 3.99 0.18 13.30 ± 0.01 0.04 
15.625 1237.8 ± 1.4 0.13 10.79 ± 0.005 0.05 1116.04 ± 2.76 0.25 13.30 ± 0.00 0.00 
7.8125 646.2 ± 0.83 0.12 10.80 ± 0.004 0.04 7977.84 ± 1.71 0.02 13.31 ± 0.00 0.00 
 
Interday 
125 8389.8 ± 1.2 0.02 10.8 ± 0.00 0.06 8018.86 ± 3.25 0.04 13.27 ± 0.02 0.18 
62.5 4487.4 ± 1.5 0.03 10.796 ± 0.00 0.05 4198.37 ± 3.82 0.09 13.27 ± 0.02 0.18 
31.25 2243.6 ± 1.1 0.05 10.798 ± 0.00 0.07 2196.84 ± 3.31 0.15 13.27 ± 0.02 0.18 
15.625 1235.4 ± 1.3 0.10 10.796 ± 0.00 0.05 1115.91 ± 2.46 0.22 13.26 ± 0.02 0.18 




125 8389.7 ± 0.14 0.00 10.797 ± 0.00 0.03 7998.35 ± 1.09 0.01 13.29 ± 0.02 0.13 
62.5 4486.6 ± 1.13 0.02 10.796 ± 0.00 0.00 4194.58 ± 0.86 0.02 13.29 ± 0.02 0.13 
31.25 2243.6 ± 0.00 0.00 10.797 ± 0.00 0.01 2195.07 ± 0.48 0.02 13.29 ± 0.01 0.10 
15.625 1236.6 ± 1.69 0.13 10.795 ± 0.00 0.01 1115.98 ± 0.21 0.02 13.28 ± 0.02 0.12 
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Table 2: Summary of α- and β-asarone calibration data on column A and B. The regression equation is (y = ax + b), where (a) is the slope and (b) is the y intercept 
 
α-Asarone 
Column A Column B 









Intraday 63.928 ± 0.01 94.712 ± 0.63 0.032 ± 0.00 0.099 ± 0.00 63.558 ± 0.13 142.06 ±4.25 0.22 ± 0.000 0.67 ± 0.001 
Interday 63.928 ± 0.01 95.170 ± 0.66 0.034 ± 0.00 0.10  ± 0.00 62.926 ± 0.87 143.54 ± 0.00 0.30 ± 0.001 0.90 ± 0.010 
β-asarone 
Intraday 66.058 ± 0.01 200.64 ± 0.54 0.027 ±0.00 0.081 ± 0.00 62.950 ± 0.03 162.60 ± 2.86 0.09 ± 
0.001 
0.27 ± 0.004 
Interday 66.066 ± 0.01 200.24 ± 0.68 0.034±0.01 0.103 ± 0.00 63.252 ± 0.12 155.64 ±0 .01 0.19 ± 
0.001 
0.59 ± 0.001 
 
 
Table 3: Summary of α- and β-asarone concentration in three extracts of different parts of P. sarmentosum 
 
Column A Column B 
Samples RT (min) α-asarone (% ± SD) RT (min) β-asarone (% ± SD) RT (min) α-asarone (% ± SD) RT (min) β-asarone (% ± SD) 
PSL-E 11.95 1.56  ± 0.001 10.78 0.08 ± 0.001 15.16 1.53 ± 0.001 13.32 0.07 ± 0.003 
PSL-EW 11.95 0.85 ± 0.001 10.78 0.09 ± 0.003 15.15 0.83 ± 0.001 13.32 0.09 ± 0.002 
PSL-W N/D N/D N/D N/D N/D N/D N/D N/D 
PSS-E 11.92 0.42 ± 0.00 N/D N/D 15.20 0.40 ± 0.002 N/D N/D 
PSS-EW 11.93 0.38 ± 0.002 N/D N/D 15.20 0.36 ± 0.001 N/D N/D 
PSS-W N/D N/D N/D N/D N/D N/D N/D N/D 
PSR-E 11.92 5.14 ± 0.001 10.78 0.15 ± 0.001 15.10 5.11 ± 0.003 13.27 0.14 ± 0.000 
PSR-EW 11.96 1.14 ± 0.002 10.8 0.01 ± 0.001 15.12 1.13 ± 0.001 13.28 0.01 ± 0.001 
PSR-W N/D N/D N/D N/D N/D N/D N/D N/D 
PSF-E 11.96 3.84 ± 0.001 10.8 0.11 ± 0.001 15.13 3.83 ± 0.01 13.36 0.12 ± 0.000 
PSF-EW 11.96 3.75 ± 0.001 10.8 0.11 ± 0.001 15.16 3.70 ± 0.001 13.36 0.10 ± 0.000 
PSF-W N/D N/D N/D N/D N/D N/D N/D N/D 
N/D: Not detected
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Figure 2: HPLC chromatograms of α- and β-asarone and P. sarmentosum extracts at 210 nm on ZORBAX Eclipse 
Plus Phenyl-Hexyl C-18 column. A = PSL-E, B = PSL-EW, C = PSL-W, D = PSR-E, E = PSR-EW, F = PSR-W, G = 




Figure 3: HPLC chromatograms of α- and β-asarone and P. sarmentosum extracts at 210 nm on ZORBAX 
Eclipse Plus C-18 column. A = PSL-E, B = PSL-EW, C = PSL-W, D = PSR-E, E = PSR-EW, F = PSR-W, G = 
PSS-E, H = PSS-EW, I = PSS-W, J = PSF-E, K = PSF-EW and L = PSF-W 
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For a long time, P. sarmentosum has been used 
as herbal remedy and food supplement, thus 
reliable procedures are needed for the 
quantitative analysis of its phytochemical 
constituents. In this study, P. sarmentosum 
extracts are analysed for their content of α- and 
β-asarone. Both α- and β-asarone are 
phenylpropanoids which have been reported to 
have cytotoxic, genotoxic, carcinogenic, psycho-
active effects in both in vitro and in vivo models 
[18,21].  
 
Based on the HPLC data, α-asarone is present 
as the major isomer in P. sarmentosum extracts 
compared to β-asarone. This study showed that 
in different parts of P. sarmentosum the 
concentration of α- and β-asarone were different 
and also varied between the extraction methods.  
 
The importance of measuring asarone in P. 
sarmentosum is to determine the best extraction 
method in order to produce a safer extract which 
is free from asarone or produce extract with 
asarone concentration within acceptable limit set 
by the food regulation bodies, i.e., 115 µg/day 
[20].  
 
One case study on Acorus calamus herbal 
preparation which contained asarone has 
produced side effects such as tachycardia, 
dizziness, tremor, irregular breathing, pallor, 
anxiety, nausea and vomiting [24]. From this 
analysis, we found that water extracts of P. 
sarmentosum are free from asarones and 




The developed HPLC method is simple, rapid 
and compatible with two different C-18 columns 
for the quantification of α- and β-asarone in P. 
sarmentosum extracts.  
 
The analysis of different extracts of various parts 
of the plant showed variations in asarone 
content. The method is promising for determining 
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